Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... Read More

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY4302814 in Healthy Participants

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending ... Read More

Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combin... Read More

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More

Balco Group AB Q3 Loss Rises

India, Oct. 26 -- Balco Group AB (B9C.F) released Loss for its third quarter of -SEK74.4 million The company's earnings came in at -SEK74.4 million, or -SEK3.23 per share. This compares with -SEK5.4 ... Read More

IIFL Finance announces cessation of director

Mumbai, Oct. 26 -- IIFL Finance announced that the tenure of T S Ramakrishnan (DIN: 09515616) as Non-Executive Nominee Director of Life Insurance Corporation of India on the Board of IIFL Finance has ... Read More

FCNR(B) rush squeezes margins; private banks feel more heat than PSU peers

New Delhi, Oct. 26 -- The aggressive mobilisation of Foreign Currency Non-Resident Bank [FCNR(B)] deposits increasingly weighed on bank margins during the September quarter, with private lenders beari... Read More

India's Jan-Aug tur imports rise 44% even as prices ease a tad in past two weeks

New Delhi, Oct. 26 -- India's tur imports in the first eight months of calendar 2026 are up 44 per cent even as the prices have eased a tad in the past two weeks. The surge in imports is amidst concer... Read More

Cyclone Arnab may take heavy rain regime away from South Peninsula

New Delhi, Oct. 26 -- Sunday's depression gathered steam at accelerated pace overnight on Monday and intensified twice over to become cyclone Arnab, the first of this north-east monsoon, over the east... Read More

Indonesian police hunt suspect in assault on Dutch tourist

Manokwari, W Papua, Oct. 26 -- Police in Manokwari, West Papua, deployed a special team and rapid-response unit on Sunday to pursue a suspect accused of assaulting a Dutch tourist identified as YD. M... Read More

• ««
• «
• 3609
• 3610
• 3611
• 3612
• 3613
• 3614
• 3615
• 3616
• 3617
• 3618
• »
• »»